I believe you are correct on NTI164 being a combined therapy hence the announcement for Rett’s ontop of the Phase ||/||| trials kicking off.
Would love an update from the CPY on how everything is travelling so far with the trial intake and if it’s begun or not, this share is just slipping further and further down due to no buys and very minimal selling. Pump it up a little guys, jeez.
Ann: NTI to Launch Phase II Clinical Trial in Rett Syndrome, page-5
Add NTI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $61.04M | |||
| Open | High | Low | Value | Volume |
| 5.9¢ | 6.0¢ | 5.8¢ | $12.55K | 212.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 272176 | 5.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.0¢ | 466957 | 2 |
View Market Depth
| Last trade - 15.47pm 02/10/2024 (20 minute delay) ? |
| NTI (ASX) Chart |